Mandel-Brehm Josh
Transaction: 08/03/2026
BUY
Change
+6,551
Price
$1.65
Filing
08/05/2026
Type
BUY
CAMP4 Therapeutics Corporation
CAMP • Biotechnology
$4.41
— 0.00 (0.00%)
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$255.47M
Growth
-7.0%
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0.04Healthy liquidity · 7.35Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:25 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$4.41
Change0.00%
Shares Out57.93M
Market Cap$255.47M
Enterprise Value$171.44M
52W Range1.41 - 7.75
Beta0.21
P/E-2.38
P/S104.83
P/B-368.64
P/FCF-8.91
EV/Sales70.35
Price$4.41
Change0.00%
Shares Out57.93M
Market Cap$255.47M
Enterprise Value$171.44M
52W Range1.41 - 7.75
Beta0.21
P/E-2.38
P/S104.83
P/B-368.64
P/FCF-8.91
EV/Sales70.35
EV/EBITDA-3.23
EV/FCF-5.98
Earnings Yield-41.98%
FCF Yield-11.23%
Dividend Yield0.00%
Gross Margin53.14%
Oper. Margin-14.88%
Profit Margin-22.99%
Debt/Eq0.04
Current Ratio7.35
Quick Ratio7.35
Revenue 5Y-7.03%
Target$10.75
Target Upside143.76%
Target Median$10.75
Target Range6.50 - 15.00
Volume50.75K
Avg Volume166.17K
EPS Surprise-0.11
Investment DNA
How strong this company looks for long-term investors
33
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
45/100
Why this score▼
Manageable debt level · 0.04Healthy liquidity · 7.35Negative growth trendWeak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 24 analyst votes · 2026-09-05
83/100
Bullish
Bullish
17
Hold
6
Bearish
1
Price Target
2026-08-14
Low
$6.50
Mean
$6.50
Median
$6.50
High
$6.50
Insider Transactions
Recent executive and insider activity
Gold Kelly
Transaction: 08/03/2026
BUY
Change
+6,551
Price
$1.65
Filing
08/05/2026
Type
BUY
Maricich Yuri
Transaction: 08/03/2026
BUY
Change
+6,551
Price
$1.65
Filing
08/05/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Mandel-Brehm Josh | BUY | +6,551 | $1.65 | 08/03/2026 | 08/05/2026 |
| Gold Kelly | BUY | +6,551 | $1.65 | 08/03/2026 | 08/05/2026 |
| Maricich Yuri | BUY | +6,551 | $1.65 | 08/03/2026 | 08/05/2026 |
| Young Richard A | BUY | +16,378 | $1.65 | 08/03/2026 | 08/05/2026 |
| Schwab Andrew J. | BUY | +3,179,558 | $0.00 | 08/03/2026 | 08/05/2026 |
| 5AM Partners VI, LLC | BUY | +3,179,558 | $0.00 | 08/03/2026 | 08/05/2026 |
| Nashat Amir | BUY | +28,000 | $4.34 | 06/10/2026 | 06/12/2026 |
| Stewart Murray | BUY | +28,000 | $4.34 | 06/10/2026 | 06/12/2026 |
| Holtzman Steven H | BUY | +28,000 | $4.34 | 06/10/2026 | 06/12/2026 |
| Schwab Andrew J. | BUY | +28,000 | $4.34 | 06/10/2026 | 06/12/2026 |
| Young Richard A | BUY | +28,000 | $4.34 | 06/10/2026 | 06/12/2026 |
| WILLIAMS DOUGLAS E | BUY | +28,000 | $4.34 | 06/10/2026 | 06/12/2026 |
| MacLean Michael F | OTHER | 0 | Not reported | 04/01/2026 | 04/03/2026 |
| MacLean Michael F | BUY | +56,000 | $4.46 | 04/01/2026 | 04/03/2026 |
| Mandel-Brehm Josh | BUY | +580,000 | $4.46 | 04/01/2026 | 04/03/2026 |
| Gold Kelly | BUY | +215,000 | $4.46 | 04/01/2026 | 04/03/2026 |
| Maricich Yuri | BUY | +215,000 | $4.46 | 04/01/2026 | 04/03/2026 |
| Tardiff Daniel | BUY | +170,000 | $4.46 | 04/01/2026 | 04/03/2026 |
| Mandel-Brehm Josh | BUY | +425,000 | $6.01 | 12/11/2025 | 12/22/2025 |
| Gold Kelly | BUY | +190,000 | $6.01 | 12/11/2025 | 12/22/2025 |